Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma.
Rawson RV, Adhikari C, Bierman C, Lo SN, Shklovskaya E, Rozeman EA, Menzies AM, van Akkooi ACJ, Shannon KF, Gonzalez M, Guminski AD, Tetzlaff MT, Stretch JR, Eriksson H, van Thienen JV, Wouters MW, Haanen JBAG, Klop WMC, Zuur CL, van Houdt WJ, Nieweg OE, Ch'ng S, Rizos H, Saw RPM, Spillane AJ, Wilmott JS, Blank CU, Long GV, van de Wiel BA, Scolyer RA.
Rawson RV, et al. Among authors: van akkooi acj, van de wiel ba, van houdt wj, van thienen jv.
Ann Oncol. 2021 Jun;32(6):766-777. doi: 10.1016/j.annonc.2021.03.006. Epub 2021 Mar 17.
Ann Oncol. 2021.
PMID: 33744385
Free article.
Clinical Trial.